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Abstract: QuickStep is a cloning method that allows seamless point integration of a DNA sequence
at any position within a target plasmid using only Q5 High-Fidelity DNA Polymerase and DpnI
endonuclease. This efficient and cost-effective method consists of two steps: two parallel asymmetric
PCRs, followed by a megaprimer-based whole-plasmid amplification. To further simplify the
workflow, enhance the efficiency, and increase the uptake of QuickStep, we replaced the asymmetric
PCRs with a conventional PCR that uses phosphorothioate (PTO) oligos to generate megaprimers with
3′ overhangs. The ease and speed of PTO-QuickStep were demonstrated through (1) right-first-time
cloning of a 1.8 kb gene fragment into a pET vector and (2) creating a random mutagenesis library for
directed evolution. Unlike most ligation-free random mutagenesis library creation methods (e.g.,
megaprimer PCR of whole plasmid [MEGAWHOP]), PTO-QuickStep does not require the gene of
interest to be precloned into an expression vector to prepare a random mutagenesis library. Therefore,
PTO-QuickStep is a simple, reliable, and robust technique, adding to the ever-expanding molecular
toolbox of synthetic biology and expediting protein engineering via directed evolution.
Keywords: cloning; QuickStep; PTO-QuickStep; random mutagenesis; directed evolution; protein
engineering; synthetic biology
1. Introduction
Molecular cloning has spurred progress throughout the life sciences [1,2]. In the late 1960s, several
laboratories independently isolated host and bacteriophage-induced DNA ligases from Escherichia
coli [3]. The first type II restriction enzyme from Haemophilus influenza (HindII) was isolated and
characterized in 1970 [4]. These landmark experiments paved the way for gene cloning using restriction
digestion and ligation, a popular method that is still widely and routinely used. As we move into the
era of synthetic biology, the field is in need of low-cost, time-efficient, and more robust methods for
high-quality DNA assembly [5]. QuickStep-Cloning was developed in response to this demand [6,7].
QuickStep is a cost-effective method for high-efficiency gene cloning that uses only Q5
High-Fidelity DNA Polymerase and DpnI endonuclease. These two enzymes are commonly found
in most research laboratories. QuickStep is a two-stage protocol, starting with the generation of
megaprimers with 3′ overhangs using two parallel asymmetric PCRs, followed by an exponential
whole-plasmid amplification (Figure 1A). The key advantages offered by QuickStep include an
exponential amplification (higher efficiency), point integration of DNA fragment at any desired
position (higher flexibility), compatibility with low-efficiency bacterial transformation methods (e.g.,
CaCl2 method), and time efficiency.
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Figure 1. Overview of QuickStep and PTO-QuickStep. (A) Major steps of the method and estimated
durations when cloning a 1 kb insert into a 7 kb recipient plasmid (adapted from [6,7]). (B) Molecular
mechanism of megaprimer synthesis via two parallel asymmetric PCRs, featured in the original
QuickStep method (B1: two asymmetric PCRs, B2: PCR purification and mixing of the products of the
two asymmetric PCRs). (C) Molecular mechanism of megaprimer synthesis utilizing phosphorothioate
(PTO) oligonucleotides, featured in PTO-QuickStep (C1: a standard PCR with PTO oligos, C2: iodine
cleavage of PTO bonds via 5 min incubation in alkaline iodine solution. The short strands of DNA
produced during the cleavage reaction are removed in a subsequent PCR purification).
The megaprimer synthesis stage in QuickStep involves two parallel asymmetric PCRs (Figure 1B),
which necessitate substantial preparation time. On top of that, megaprimers with 3′ overhangs
are created by preparing an equimolar mixture of the two asymmetric PCR products. Ideally, each
asymmetric PCR would produce only single-stranded DNA (ssDNA) as product, which forms a
building block for the double-stranded megaprimer. In reality, the complementary strands with 5′
extension are also produced in each asymmetric PCR, albeit in a smaller amount. When the products
of both asymmetric PCRs are mixed, these complementary strands with 5′ extension can either anneal
(1) to 5′ extended strands, resulting in the formation of megaprimers with 5′ overhangs or (2) to 3′
extended strands, giving rise to blunt-ended megaprimers, as illustrated in Figure 1B. These two types
of undesired double-stranded megaprimers are “nonproductive” as they cannot be extended in the
subsequent whole-plasmid amplification stage. To eliminate these two problems (the need for two
asymmetric PCRs and the presence of the undesired megaprimers) and further simplify the method,
we proposed phosphorothioate (PTO)-QuickStep. In this streamlined protocol, we replaced the two
parallel asymmetric PCRs with a single conventional PCR using PTO oligonucleotides (Figure 1C). 3′
overhangs were subsequently exposed by a short megaprimer incubation in alkaline iodine solution.
The PTO bond substitutes a sulfur atom for a nonbridging oxygen in the phosphate backbone
of an oligonucleotide. PTO modification renders the internucleotide linkage more resistant to
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nuclease degradation [8], which explains why this modification is commonly employed in therapeutic
oligonucleotides [9]. PTO bond also exhibits chemical stability similar to a phosphodiester linkage [9].
Another interesting feature of PTO bond is that it is susceptible to iodine cleavage in alkaline
solution. Selective strand cleavage is achieved through alkylation to form the hydrolytically labile
PTO trimester [10]. This specific feature has been exploited in the development of several molecular
biology tools, such as sequence saturation mutagenesis (random mutagenesis) [11–13], OmniChange
(focused mutagenesis) [14], and PLICing (gene cloning) [15].
In this article, we present the optimized PTO-QuickStep. We demonstrated the applicability of
PTO-QuickStep by applying it to cloning of the gene encoding the reductase domain of cytochrome
P450 BM-3 (cpr, ~1.8 kb). We further extended the method to create a random mutagenesis library
of a red fluorescent protein (mRFP1). This was the first attempt of coupling PTO-QuickStep and
random mutagenesis.
2. Results and Discussion
2.1. PTO-QuickStep and its Optimization
PTO-QuickStep was designed to streamline QuickStep-Cloning, which was reported previously
by our group [6,7]. The objective was twofold: (1) to reduce the preparation time by replacing two
parallel asymmetric PCRs with a single conventional PCR and (2) to remove unwanted by-products
during megaprimer preparation (Figure 1B). Compared to QuickStep, which requires four primers,
PTO-QuickStep utilizes only two oligonucleotides, each containing two PTO modifications (Figure 1C
and Table 1). PTO bonds were selectively cleaved by adding alkaline iodine solution to expose the 3′
overhangs. We strategically incorporated two PTO modifications to build in a “fail-safe” mechanism
in our design (Figure 1C). Even if only one PTO bond was cleaved (i.e., incomplete iodine cleavage),
the subsequent exponential megaprimer-based whole-plasmid amplification would still work. On top
of that, shorter DNA fragments (half the length) were generated from iodine cleavage when two PTO
modifications were used, which facilitated the subsequent removal of cleaved DNA fragments via a
silica-based PCR purification.
Table 1. Primers used in this study (* represents the location of PTO modification, and DNA sequence
in lowercase denotes the region complementary to the recipient plasmid).
Name Length [bp] Sequence (5′→3′)
RFP-Fwd 19 ATGGCGAGTAGCGAAGACG
RFP-Rev 21 TTAAGCACCGGTGGAGTGACG
IntA-RFP-Fwd 47 cgaaaacctgtacttccagggtggatccATGGCGAGTAGCGAAGACG
IntB-RFP-Rev 47 ctaggatctgactgcggctcctccatTTAAGCACCGGTGGAGTGACG
IntA-RFP-Fwd-PTO 47 cgaaaacctgtact*tccagggtggatcc*ATGGCGAGTAGCGAAGACG
IntB-RFP-Rev-PTO 47 ctaggatctgact*gcggctcctccat*TTAAGCACCGGTGGAGTGACG
IntA-CPR-Fwd 56 ggtaaaagcaaaatcgaaaaaaattccgcttGGCGGTATTCCTTCACCTAGCACTG
IntB-CPR-Rev 43 gtcgacggagctcgaattcttaCCCAGCCCACACGTCTTTTGC
IntA-CPR-Fwd-PTO 56 ggtaaaagcaaaatc*gaaaaaaattccgctt*GGCGGTATTCCTTCACCTAGCACTG
IntB-CPR-Rev-PTO 43 gtcgacggagc*tcgaattctta*CCCAGCCCACACGTCTTTTGC
PTO-QuickStep was optimized using an rfp cloning experiment, where rfp gene from pBbA8k-RFP
(Kanr; donor plasmid) was cloned into pET24a-HLTev-p53 (Kanr; recipient plasmid). This rfp gene
encodes the monomeric mRFP1, originally derived from the Discosoma sp. red fluorescent protein
(DsRed) [16]. For the first stage of PTO-QuickStep (megaprimer preparation), two parameters were
investigated: (1) iodine cleavage time and (2) the effect of a PCR mix on the efficiency of iodine
cleavage. For the second stage of PTO-QuickStep (megaprimer PCR), three parameters were studied:
(1) megaprimer concentration, (2) number of PCR cycles, and (3) recipient plasmid concentration.
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After the PCR with PTO oligonucleotides, 6.25 µL of 0.5 M Tris-HCl buffer (pH 9) and 6.25 µL of
100 mM iodine in absolute ethanol were added directly to the PCR product (50 µL). After mixing, the
mixture was incubated for 5 min at 70 ◦C and then snap-cooled on ice to prevent the cleaved DNA
fragments from reannealing to the exposed 3′ overhangs. A quick silica column-based PCR purification
was conducted before proceeding to the megaprimer PCR. This PCR purification step is necessary for
two purposes: (1) to remove the cleaved DNA fragments, which are ssDNA molecules of 11–16 bases
assuming a complete iodine cleavage of both PTO bonds (with a QIAquick PCR purification, only
DNAs of 100 bp to 10 kb are purified) and (2) to remove ethanol that interferes with any downstream
enzymatic reaction. As shown in Figure 2A, there was no discernible difference when the incubation
time in iodine solution was extended from 5 min to 2 h. We also investigated whether there was a need
to add an additional PCR purification step just before the iodine cleavage. It is clear from Figure 2B
that an extra PCR purification step barely altered the final PCR yield. This indicated that the PCR mix
did not interfere with the iodine cleavage, which was also observed in other studies [11–13].
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product yield with increasing number of PCR cycles (Figure 2D and Table 2). However, as we 
increased the number of PCR cycles, we also noticed more side-products (indicated by the smears 
above and below the product band; Figure 2D). For 35 cycles, the higher PCR product yield did not 
translate into higher cloning efficiency (Figure 2D). This was most likely caused by a high amount of 
side-products that interfered with the subsequent chemical transformation. The same trend was 
observed when we varied the recipient plasmid concentration. Higher PCR product yield was 
obtained when we increased vector concentration, which was also accompanied with a higher side-
product formation (Figure 2E). Therefore, 2 ng/µL (5 nM) of megaprimer, 30 cycles, and 0.4 ng/µL of 
Figure 2. Optimization of PTO-QuickStep. The DNA gel shows the yield of megaprimer PCR (A)
for different iodine cleavage times, (B) with and without an additional PCR purification step prior to
iodine cleavage, (C) for different megaprimer concentrations, (D) for different number of PCR cycles,
and (E) for different recipient plasmid concentrations.
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Learning from our previous experience [6,7], the efficiency of exponential megaprimer-based
whole-plasmid amplification is significantly influenced by megaprimer concentration, the number
of PCR cycles, and recipient plasmid concentration. By varying megaprimer concentration between
0.25 ng/µL to 16 ng/µL, it was determined that the optimal PCR yield occurred at 2 ng/µL of megaprimer,
which is equivalent to a concentration of 5 nM (Figure 2C). Generally, we observed higher PCR product
yield with increasing number of PCR cycles (Figure 2D and Table 2). However, as we increased the
number of PCR cycles, we also noticed more side-products (indicated by the smears above and below
the product band; Figure 2D). For 35 cycles, the higher PCR product yield did not translate into higher
cloning efficiency (Figure 2D). This was most likely caused by a high amount of side-products that
interfered with the subsequent chemical transformation. The same trend was observed when we varied
the recipient plasmid concentration. Higher PCR product yield was obtained when we increased
vector concentration, which was also accompanied with a higher side-product formation (Figure 2E).
Therefore, 2 ng/µL (5 nM) of megaprimer, 30 cycles, and 0.4 ng/µL of vector were chosen to be the most
optimal conditions for a megaprimer PCR based on two considerations, namely, the amount of PCR
side-products and the number of transformants obtained.
Table 2. Comparison of cloning efficiencies: QS: QuickStep; RF: restriction-free (RF) cloning; PTO-QS:
PTO-QuickStep (*Numbers in bracket represent RFP-expressing clones; **intact recipient plasmids
were used as reference plasmids; N/A = not applicable; N/D = not determined).
Target Gene/
Recipient Plasmid
Strain/
Transformation
Method
QS* RF* PTO-QS(25 cycles)*
PTO-QS
(30 cycles)* MEGAWHOP
Transformation
Efficiency
[cfu/µg]**
rfp/
pET24a-HLTev-p53
E. coli DH5α/
Chemical 9 (9) 0 (0) 19 (16) 43 (41) N/A 2.0 × 104
cpr/
pETM11-BMP-WT
E. coli DH5α/
Chemical N/D 0 49 N/D N/A 4.0 × 104
rfp library/
pET24a-HLTev-p53
E. coli C41 (DE3)/
Electroporation N/D N/A 1.0 × 104 N/D 1.5 × 104 2.0 × 106
2.2. PTO-QuickStep is Superior to QuickStep-Cloning and RF Cloning
The optimized PTO-QuickStep was then compared to QuickStep-Cloning [6,7] and restriction-free
(RF) cloning [17] by conducting the same rfp gene cloning using identical primer design and recipient
plasmid to allow an objective and fair assessment. All PCR products were transformed directly into E.
coli C41 (DE3) strain for a T7-driven mRFP1 protein expression, using the standard CaCl2 method.
As evidenced in Table 2, PTO-QuickStep was clearly superior in terms of efficiency and accuracy.
Compared to QuickStep, PTO-QuickStep showed a 2- to 4-fold improvement in cloning efficiency,
depending on the number of PCR cycles used. At the same time, the percentage of mRFP1-positive
clones remained exceptionally high (84% for PTO-QuickStep and 100% for QuickStep). The low
percentage of mRFP1-negative clones (potentially caused by deleterious mutations such as frameshift
or point mutation) means that both PTO-QuickStep and QuickStep are characterized by a high degree
of fidelity. On the other hand, RF cloning failed to produce a single colony. This was consistent
with the observation that the megaprimer PCR of RF cloning did not yield a distinct PCR product
band (Figure 3A). The unsuccessful RF cloning could be attributed to two factors: (1) RF cloning is
not designed for point integration of a gene into a recipient plasmid, and (2) RF cloning requires a
transformation method of much higher efficiency (e.g., electroporation or ultracompetent cells).
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Figure 3. (A) Megaprimer PCR yield of RF cloning, QuickStep and PTO-QuickStep in the rfp cloning
experiment. (B) Yield of RF cloning and PTO-QuickStep in the cpr cloning experiment. (C) Colony PCR
confirming the pr sence of cpr gene in all five randomly s lected clones from the cloning experiment
using PTO-QuickStep.
It is important to note that all methods tested in this study (PTO-QuickStep, QuickStep, and
RF) generated nicked circular plasmids. After transformation, E. coli cells repaired the nicks in the
plasmids. We also did a parallel transformation using intact circular plasmid (in this case, the recipient
plasmid pET24a-HLTev-p53) as a reference. We achieved a transformation efficiency of 2 × 104 cfu/µg
(Table 2), which is equivalent to 20 colonies per 1 ng of intact plasmid. This benchmark was necessary
for two reasons: (1) the number of tra sformants obtained in a gene cloning depends on the strain
and the tran formation method used, and (2) it is impossible to quantify the exact concentration of
the desir d product from megaprimer PCR du to the presence of unavoidable side-products. The
transformation efficiency of a nicked plasmid is widely known to be lower than that of an intact
plasmid. This explains why the numbers of transformants from all cloning methods were lower than
that of the reference plasmid.
2.3. Right-First-Time Cloning of P450 BM-3 Reductase Gene (cpr)
rfp (678 bp) is a relatively short gene. To prove that the optimized protocol is versatile and
applicable to cloning other longer genes without the need for further optimization, we applied
PTO-QuickStep to cloning P450 BM-3 reductase gene (cpr; 1782 bp) from pCWori-BM3 (Ampr; donor
plasmid) nto pETM11-BMP-WT ( ; recipient plasmid). This cloning wa consid red technically
more challenging as the target gene (~1.8 kb) and the recipient plasmid (~7.4 kb) would give a combined
product of ~9.2 kb. Typically, the number of transformants decreases with the increase in plasmid
size. To serve as a comparison, we performed RF cloning concurrently. To ensure that any observed
differences originate from the intrinsic molecular mechanisms underlying the two cloning methods,
the number of cycles for megaprimer PCR was set to 25, which is the recommended number for RF
cloning. Owing to the large product size and an insert that was nearly 3 times longer, the PCR product
yield was much lower (Figure 3B) compared to rfp cloning xperim nt (Fi ure 3A). Despite the low
DNA amount, judging from the DNA gel, we obtained a significant number of transformants (Table 2).
Five of the 49 colonies were randomly picked, and the presence of cpr gene was confirmed for all five
clones (100% accuracy; Figure 3C). The clones were sequence verified and gave the expected P450
BM-3 activity (data not shown), proving the high fidelity of PTO-QuickStep. Once again, RF cloning
did not produce a colony, further confirming our initial hypotheses that RF cloning is not designed for
point integration of a gene and/or it requires a more efficient transformation method.
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2.4. Applying PTO-QuickStep for Directed Protein Evolution
To maximize the potential of PTO-QuickStep, we applied the protocol to prepare a random
mutagenesis library for directed evolution. rfp gene was once again used as a model system.
However, this time, random mutations were introduced into rfp gene by amplifying the gene using
PTO oligonucleotides and Taq DNA polymerase in the presence of imbalanced deoxynucleoside
triphosphate (dNTP) concentrations and MnCl2. In other words, a standard error-prone PCR (epPCR)
condition was used. After the epPCR and iodine cleavage, we proceeded to megaprimer PCR as per
usual. Again, for a more objective comparison, 25 cycles of megaprimer PCR were used. Concurrently,
we prepared another random mutagenesis library following the megaprimer PCR of whole plasmid
(MEGAWHOP) protocol [18]. It should be noted that, in order to perform MEGAWHOP, the target
gene (in this case, rfp gene) must first be precloned into the expression vector. This prerequisite
would mean an extra step when applying MEGAWHOP compared to PTO-QuickStep. However,
the advantage is a higher number of transformants due to better annealing of the megaprimers (the
complementary region is essentially the entire target gene). When we transformed the products of
both PTO-QuickStep and MEGAWHOP into E. coli C41 (DE3) using electroporation, we obtained
comparable library sizes (Table 2), despite the fact that a suboptimal number of cycles (25 instead of 30)
for megaprimer PCR was used for PTO-QuickStep to allow for an objective comparison between the
two methods. Contrary to gene cloning experiments described above, electroporation was applied
here to demonstrate that the number of transformants obtained (and consequently the library size
in the case of a directed evolution experiment) can easily be upscaled through a more efficient
transformation method. It is worth noting that a transformation efficiency of 2 × 106 cfu/µg DNA
was obtained using electrocompetent cells prepared in-house. This efficiency is far lower than that
of commercially available ultracompetent cells (>1 × 109 and >1 × 1010 cfu/µg pUC19 DNA for
chemically competent and electrocompetent cells, respectively). As such, the library size can be further
increased by more than three orders of magnitude by combining the product of PTO-QuickStep with
commercial ultracompetent cells. Nonetheless, our data showed that both chemical transformation
and electroporation are compatible with PTO-QuickStep. The choice is dependent on the number of
transformants required and the application.
2.5. mRFP1 Variants Isolated from PTO-QuickStep Library
Three mRFP1 protein variants exhibiting a different color under visible light were isolated from
the PTO-QuickStep rfp library for further characterization (Figure 4). These variants displayed different
absorption spectra (Figure 5). The purified mRFP1 wild type showed an excitation maximum of 585
nm, consistent with previously reported values [16,19,20]. All variants (M1–M3) had blue-shifted
excitation maxima. M1, the brightest variant of all, had two absorption peaks of almost equal height at
503 nm and 584 nm.
DNA sequencing revealed nonsynonymous mutations in all three variants (Table 3). In fact, the
profile of nucleotide substitutions obtained (A→T, A→G, T→C) was consistent with the expected
mutational spectrum of the epPCR condition chosen [21]. Interestingly, two of the four mutated
amino acid positions (Q66 and T195) are also the key determinants in creating DsRed variants
(e.g., dTomato [16], mCherry [16], mStrawberry [16], mTangerine [16], mOrange [16], mBanana [16],
mHoneydew [16], pHTomato [22], and an improved mRFP1 variant reported by Jach et al. [19]).
Therefore, PTO-QuickStep enabled fast and efficient creation of good-quality mutant library for
directed evolution.
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Figure 4. Comparison between mRFP1 wild type (WT) and the three variants (M1, M2, and M3) isolated
from the PTO-QuickStep library. (A) Cell pellets of E. coli C41 (DE3) expressing the red fluorescent
proteins. (B) Proteins purified using Ni-NTA Spin Columns (Qiagen). (C) Purified proteins under UV
light. (-ve) denotes egative control, i.e., E. coli C41 (DE3) without a plasmid.
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[M1 (green), M2 (purple), and M3 (blue)].
Table 3. Nucleotide and amino acid substitutions found in the three isolated RFP variants (M1, M2,
and M3).
RFP Variants Nucleotide Substitution Amino Acid Substitution
M1 ACC→ TCC T195S
M2 TTC→ CTC F91L
M3
CAG→ CTG Q66L
ACC→ GCC T202A
2.6. PTO-QuickStep: Potential Limitations and Mitigation
PTO-QuickStep is a significant advancement of the established QuickStep method for seamless
cloning of either a specific DNA sequence or a gene library for directed evolution. Therefore,
PTO-QuickStep is expected to facilitate day-to-day molecular cloning and expedite the directed
evolution workflow. As demonstrated in this article, PTO-QuickStep can easily be coupled with
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different transformation methods, depending on application and need. For example, electroporation
generates a larger library for directed evolution experiment. Potential means to further increase the
library size include the use of commercially available ultracompetent cells or treating the PTO-QuickStep
product with nick-repairing enzymes prior to transformation (e.g., New England Biolabs’ PreCR
Repair Mix).
As is the case with most PCRs or PCR-based methods, the success hinges on the correct primer
design. PTO-QuickStep requires only a pair of PTO-modified primers compared to four primers
needed for QuickStep. This change should minimize the chances of incorrect primer design. As PTO
chemistry is one of the cheapest oligonucleotide modifications available, both primer configurations
have the same price (£12 for either a pair of desalted PTO primers used for RFP-cloning experiments or
four desalted unmodified oligos needed for the original QuickStep, as given by Eurofins Genomics).
It should be pointed out that both PTO-QuickStep and QuickStep are optimized for point insertion
of DNA. They are not the methods of choice for gene replacement. Furthermore, the method has not been
tested for simultaneous cloning of multiple fragments, although there is a possibility of incorporating
an overlapping PCR into the method to create a megaprimer composed of several fragments.
A comparison between the rfp and cpr cloning experiments (Table 2 and Figure 3) indicates that
the cloning efficiency decreases with increasing length of either the target gene or the recipient plasmid,
with the latter appearing to have a more profound effect. This is often observed with methods relying
on whole-plasmid amplification, such as the QuikChange protocols for focused mutagenesis. As
such, for more challenging cloning experiments (for example, when a target gene is longer than 2 kb),
a standard CaCl2 chemical transformation protocol might prove insufficient, and the use of a more
efficient transformation method (e.g., electroporation or commercially available competent cells) is
therefore advised.
3. Materials and Methods
3.1. Materials
All enzymes, deoxyribonucleotides, and DNA ladders were purchased from New England Biolabs
Ltd. (Hitchin, UK).
3.2. Primers
All primers used in this study (Table 1) were synthesized by Eurofins Genomics (Ebersberg,
Germany). The melting temperatures of oligonucleotides were determined using the NEB Tm calculator
(https://tmcalculator.neb.com/#!/main).
3.3. QuickStep-Cloning
To clone rfp gene from pBbA8k-RFP into pET24a-HLTev-p53, two asymmetric PCRs were carried
out in parallel. Asymmetric PCR mixture I (50 µL) contained 1× Q5 reaction buffer, 200 µM of
each dNTP, 500 nM RFP-Fwd primer, 10 nM IntB-RFP-Rev primer, 0.2 ng pBbA8k-RFP, and 1 U Q5
High-Fidelity DNA Polymerase. Asymmetric PCR mixture II (50 µL) contained 1× Q5 reaction buffer,
200 µM of each dNTP, 10 nM IntA-RFP-Fwd primer, 500 nM RFP-Rev primer, 0.2 ng pBbA8k-RFP,
and 1 U Q5 High-Fidelity DNA Polymerase. Both mixtures were thermocycled using the following
conditions: (i) 30 s initial denaturation at 98 ◦C and (ii) 30 cycles of 7 s denaturation at 98 ◦C, 20 s
annealing at 68 ◦C, and 30 s extension at 72 ◦C. The two PCR products were purified using QIAquick
PCR Purification Kit (Qiagen, Manchester, UK), and their DNA concentrations were determined using
VersaWave Microvolume Spectrophotometer (Expedeon, Cambridge, UK). For megaprimer PCR, the
mixture (50 µL) contained 1× Q5 reaction buffer, 200 µM of each dNTP, 200 ng of purified asymmetric
PCR product I, 200 ng of purified asymmetric PCR product II, 20 ng pET24a-HLTev-p53, and 1 U Q5
High-Fidelity DNA Polymerase. The mixture was thermocycled using the following conditions: (i) 30 s
initial denaturation at 98 ◦C; (ii) 25 cycles of 10 s denaturation at 98 ◦C, 4 min annealing and extension
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at 72 ◦C; and (iii) 2 min final extension at 72 ◦C. Forty units of DpnI were subsequently added to the
PCR mixture and incubated at 37 ◦C for 15 min to remove the parental plasmids.
3.4. Restriction-Free (RF) Cloning
PCR mixture (50 µL) containing 1×Q5 reaction buffer, 200 µM of each dNTP, 500 nM IntA-RFP-Fwd
primer, 500 nM IntB-RFP-Rev primer, 0.2 ng pBbA8k-RFP, and 1 U Q5 High-Fidelity DNA Polymerase
was thermocycled using the same program as the asymmetric PCR in QuickStep-Cloning: (i) 30 s initial
denaturation at 98 ◦C and (ii) 30 cycles of 7 s denaturation at 98 ◦C, 20 s annealing at 68 ◦C, and 30 s
extension at 72 ◦C. The PCR product was purified using QIAquick PCR Purification Kit (Qiagen), and its
DNA concentration was determined using VersaWave Microvolume Spectrophotometer. Megaprimer
PCR mixture (50 µL) containing 1× Q5 reaction buffer, 200 nM of each dNTP, 400 ng of purified PCR
product, 20 ng pET24a-HLTev-p53, and 1 U Q5 High-Fidelity DNA Polymerase was thermocycled
using the following conditions: (i) 30 s initial denaturation at 98 ◦C; (ii) 25 cycles of 10 s denaturation at
98 ◦C, 4 min annealing and extension at 72 ◦C; and (iii) 2 min final extension at 72 ◦C. Forty units of DpnI
were added to the PCR mixture and incubated at 37 ◦C for 15 min to remove the parental plasmids.
To clone P450 BM-3 reductase gene (cpr) from pCWori-BM3 into pETM11-BMP-WT, the same
protocol was followed using a dedicated primer set (IntA-CPR-Fwd and IntB-CPR-Rev). For the first
PCR, the following thermocycling conditions were used: (i) 30 s initial denaturation at 98 ◦C and
(ii) 30 cycles of 7 s denaturation at 98 ◦C, 80 s annealing and extension at 72 ◦C. The PCR product
was purified as described above. Subsequently, megaprimer PCR mixture (50 µL) containing 1× Q5
reaction buffer, 200 nM of each dNTP, 500 ng of purified PCR product, 25 ng pETM11-BMP-WT, and 1
U Q5 High-Fidelity DNA Polymerase was thermocycled using the following conditions: (i) 30 s initial
denaturation at 98 ◦C; (ii) 25 cycles of 10 s denaturation at 98 ◦C, 20 s annealing at 66 ◦C, and 4 min
extension at 72 ◦C; and (iii) 2 min final extension at 72 ◦C. Forty units of DpnI were added to the PCR
mixture and incubated at 37 ◦C for 15 min to remove the parental plasmids.
3.5. PTO-QuickStep
PCR mixture (50 µL) containing 1× Q5 reaction buffer, 200 µM of each dNTP, 500 nM
IntA-RFP-Fwd-PTO primer, 500 nM IntB-RFP-Rev-PTO primer, 0.2 ng pBbA8k-RFP, and 1 U Q5
High-Fidelity DNA Polymerase was thermocycled using the same program as the asymmetric PCR in
QuickStep-Cloning: (i) 30 s initial denaturation at 98 ◦C and (ii) 30 cycles of 7 s denaturation at 98 ◦C,
20 s annealing at 68 ◦C, and 30 s extension at 72 ◦C.
After PCR, 6.25 µL of 0.5 M Tris-HCl buffer (pH 9) and 6.25 µL of 100 mM iodine in absolute
ethanol were added directly to the PCR product. After brief mixing by pipetting, the mixture was
incubated for 5 min at 70 ◦C and then snap-cooled on ice.
Subsequently, the mixture was purified using QIAquick PCR Purification Kit (Qiagen), and its
DNA concentration was determined using VersaWave Microvolume Spectrophotometer. Megaprimer
PCR mixture (50 µL) containing 1× Q5 reaction buffer, 200 nM of each dNTP, 100 ng of purified PCR
product, 20 ng pET24a-HLTev-p53, and 1 U Q5 High-Fidelity DNA Polymerase was thermocycled
using the same program as the QuickStep-Cloning megaprimer PCR: (i) 30 s initial denaturation at
98 ◦C; (ii) 25 cycles of 10 s denaturation at 98 ◦C, 4 min annealing and extension at 72 ◦C; and (iii) 2 min
final extension at 72 ◦C. Forty units of DpnI were added to the PCR mixture and incubated at 37 ◦C for
15 min to remove the parental plasmids.
To clone P450 BM-3 reductase gene (cpr) from pCWori-BM3 into pETM11-BMP-WT, the same
protocol was followed using a dedicated primer set (IntA-CPR-Fwd-PTO and IntB-CPR-Rev-PTO). For
the first PCR, the following thermocycling conditions were used: (i) 30 s initial denaturation at 98 ◦C
and (ii) 30 cycles of 7 s denaturation at 98 ◦C, 80 s annealing and extension at 72 ◦C. The PCR product
was purified as described above. Subsequently, megaprimer PCR mixture (50 µL) containing 1× Q5
reaction buffer, 200 nM of each dNTP, 100 ng of purified PCR product, 25 ng pETM11-BMP-WT, and 1
U Q5 High-Fidelity DNA Polymerase was thermocycled using the following conditions: (i) 30 s initial
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denaturation at 98 ◦C; (ii) 25 cycles of 10 s denaturation at 98 ◦C, 20 s annealing at 66 ◦C, and 4 min
extension at 72 ◦C; and (iii) 2 min final extension at 72 ◦C. Forty units of DpnI were added to the PCR
mixture and incubated at 37 ◦C for 15 min to remove the parental plasmids.
3.6. DNA Gel Electrophoresis
PCR products were analyzed using 0.7% tris-borate-ethylenediaminetetraacetic acid (TBE) gel.
For visualization purposes, ethidium bromide was added to the gel. Quick-Load 1 kb DNA Ladder
was used as a DNA ladder.
3.7. Chemical Transformation and Clone Analysis
E. coli DH5α and C41 (DE3) were transformed with 5 µL of DpnI-digested products of
QuickStep-Cloning, RF cloning, or PTO-QuickStep using a standard CaCl2 chemical transformation
protocol. Concurrently, the bacterial strains were transformed with 1 ng of intact pET24a-HLTev-p53 or
pETM11-BMP-WT to estimate the transformation efficiency. Transformed bacteria were plated on TYE
agar plates (10 g/L tryptone, 5 g/L yeast extract, 8 g/L sodium chloride, and 15 g/L agar) supplemented
with 50 µg/mL kanamycin and 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) (only for rfp
cloning experiment). The plates were incubated overnight at 37 ◦C and for a further 12 h at 30 ◦C. The
number of mRFP1-expressing colonies was determined by visual inspection using UV transilluminator.
3.8. Error-Prone PCR
PCR mixture (50 µL) containing 1× Standard Taq (Mg-free) reaction buffer, 7 mM MgCl2, 0.05
mM MnCl2, 200 µM of deoxyadenosine triphosphate (dATP), 200 µM of deoxyguanosine triphosphate
(dGTP), 1 mM of deoxythymidine triphosphate (dTTP), 1 mM of deoxycytidine triphosphate (dCTP),
400 nM IntA-RFP-Fwd-PTO or IntA-RFP-Fwd primer (depending on whether PTO-QuickStep or
MEGAWHOP was used, respectively), 400 nM IntB-RFP-Rev-PTO or IntB-RFP-Rev primer, 50 ng
pBbA8k-RFP, and 1.25 U Taq DNA Polymerase was thermocycled using the same program as the
asymmetric PCR in QuickStep-Cloning: (i) 30 s initial denaturation at 95 ◦C; (ii) 30 cycles of 20 s
denaturation at 95 ◦C, 30 s annealing at 55 ◦C, and 45 s extension at 68 ◦C; and (iii) final extension at
68 ◦C for 5 min. The PCR product was purified using QIAquick PCR Purification Kit (Qiagen), and its
DNA concentration was determined using VersaWave Microvolume Spectrophotometer.
3.9. MEGAWHOP
Megaprimer PCR mixture (50 µL) containing 1× Q5 reaction buffer, 200 nM of each dNTP,
500 ng megaprimer, 50 ng pET24a-HLTev-RFP-p53, and 1 U Q5 High-Fidelity DNA Polymerase was
thermocycled using the following conditions: (i) 30 s initial denaturation at 98 ◦C; (ii) 25 cycles of 10 s
denaturation at 98 ◦C, 4 min annealing and extension at 72 ◦C; and (iii) 2 min final extension at 72 ◦C.
Forty units of DpnI were added to the PCR mixture and incubated at 37 ◦C for 15 min to remove the
parental plasmids.
3.10. Transformation of mRFP1 Library
The products of PTO-QuickStep and MEGAWHOP were purified using QIAquick PCR Purification
Kit (Qiagen). One microliter of the purified mixture was used to transform E. coli C41 (DE3) cells
using a standard electroporation protocol. After the transformation, the cells were plated at different
dilutions on Luria–Bertani (LB) agar plates (10 g/L tryptone, 5 g/L yeast extract, 10 g/L sodium chloride,
and 15 g/L agar) supplemented with 50 µg/mL kanamycin and 1 mM IPTG. The plates were incubated
overnight at 37 ◦C and for a further 12 h at 30 ◦C. Three colonies exhibiting a different color under
visible light compared to that of the mRFP1 wild type were identified by visual inspection and were
grown overnight at 37 ◦C in 5 mL 2× TY medium (16 g/L tryptone, 10 g/L yeast extract, and 5 g/L NaCl)
supplemented with 50 µg/mL kanamycin.
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3.11. mRFP1 Expression and Purification
Overnight cultures (250 µL) of E. coli C41 (DE3) corresponding to mRFP1 wild type and the three
isolated variants were used to inoculate 50 mL LB medium supplemented with 50 µg/mL kanamycin
and grown at 37 ◦C with shaking. When OD600 reached 0.6, the expression was induced with 1 mM
IPTG. The cells were grown for a further 16 h. The proteins were purified using Ni-NTA Spin Columns
(Qiagen) according to the manufacturer’s instructions. The absorbance measurements were conducted
using UV-1600PC UV-VIS spectrophotometer (VWR International, Lutterworth, UK).
4. Conclusions
By applying two PTO modifications and strategically placing these PTO bonds within the
PCR primers, we streamlined the workflow of QuickStep, enhanced its efficiency, and extended its
application to directed evolution. PTO-QuickStep would be of great interest to the synthetic biology
community as it facilitates fast, flexible, and efficient construction of recombinant plasmids. This study
has also demonstrated that PTO-QuickStep is expected to make a significant contribution to the field
of protein engineering.
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Abbreviations
bp base pair
cfu colony-forming unit
DNA deoxyribonucleic acid
dATP deoxyadenosine triphosphate
dCTP deoxycytidine triphosphate
dGTP deoxyguanosine triphosphate
dNTP deoxynucleoside triphosphate
dTTP deoxythymidine triphosphate
epPCR error-prone polymerase chain reaction
IPTG isopropyl β-D-1-thiogalactopyranoside
kb kilobase
LB Luria–Bertani
MEGAWHOP megaprimer PCR of whole plasmid
PCR polymerase chain reaction
PTO phosphorothioate
RF restriction-free
RFP red fluorescent protein
ssDNA single-stranded deoxyribonucleic acid
TBE tris-borate-ethylenediaminetetraacetic acid
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